1-14 of 14
Ju Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Golcadomide (GOLCA; CC-99282), a Novel CELMoD Agent, Plus R-CHOP in Patients (pts) with Previously Untreated Aggressive B-Cell Lymphoma (a-BCL): Safety and Efficacy Results from Phase 1b Dose Expansion

Marc S. Hoffmann, Javier L. Munoz, Jason Westin, Theodoros Vassilakopoulos, Alejandro Martin Garcia-Sancho, Antonio Rueda Dominguez, Wojciech Jurczak, Su-Peng Yeh, Maria Bouzani, Argyrios Gkasiamis, Mark Kaplan, Arpankumar Patel, Floriane Boucaud, Ju Li, Grzegorz S. Nowakowski
Journal: Blood
Blood (2023) 142 (Supplement 1): 4459.
https://doi.org/10.1182/blood-2023-174242
Published: 2023
Journal Articles

Iberdomide (CC-220) Monotherapy or in Combination with an Anti-CD20 Monoclonal Antibody As Effective Therapy in Patients with Relapsed/Refractory Lymphoma: Early Results from a Phase 1/2 Study

Catherine Thieblemont, Javier Munoz, Alessandra Tucci, Carlo Visco, Guillaume Cartron, Paolo Corradini, Ian W. Flinn, Thomas Gastinne, Kamal Krimo Bouabdallah,, Luca Arcaini, Grzegorz S. Nowakowski, Louise Roulin, Max Topp, Shekeab Jauhari, Vladan Vucinic, Peter Martin, Argyrios Gkasiamis, James Drew, Parth Rao, Mark Kaplan, Yiming Cheng, Ju Li, Franck Morschhauser
Journal: Blood
Blood (2022) 140 (Supplement 1): 569–572.
https://doi.org/10.1182/blood-2022-162559
Published: 2022
Journal Articles

Phase 1b Trial of Cereblon-Modulating Agents Iberdomide and CC-99282 Plus R-CHOP in Previously Untreated Aggressive B-Cell Lymphoma

Jason Westin, Alejandro Martín García-Sancho, Marc Hoffmann, Theodoros P. Vassilakopoulos, Su-Peng Yeh, Argyrios Gkasiamis, Poliana Patah, Arpankumar Patel, Ju Li, Grzegorz S. Nowakowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 9475–9477.
https://doi.org/10.1182/blood-2022-162774
Published: 2022
Journal Articles

Completed Induction Phase Analysis of Magnify: Phase 3b Study of Lenalidomide + Rituximab (R 2 ) Followed By Maintenance in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Frederick Lansigan, David Jacob Andorsky, Morton Coleman, Abdulraheem Yacoub, Jason Melear, Suzanne Fanning, Kathryn S. Kolibaba, Christopher M. Reynolds, Grzegorz S. Nowakowski, Mecide Gharibo, Jung Ryun Ahn, Ju Li, Mathias J. Rummel, Jeff P. Sharman
Journal: Blood
Blood (2021) 138 (Supplement 1): 812.
https://doi.org/10.1182/blood-2021-145640
Published: 2021
Journal Articles

Patients with Relapsed/Refractory Marginal Zone Lymphoma in the MAGNIFY Phase IIIb Interim Analysis of Induction R 2 Followed By Maintenance

Morton Coleman, MD FACP, David Jacob Andorsky, MD, Abdulraheem Yacoub, MD, Jason M. Melear, MD, Suzanne R. Fanning, DO, Kathryn S. Kolibaba, MD, Frederick Lansigan, MD, Christopher M. Reynolds, MD, Grzegorz S. Nowakowski, MD, Mecide Gharibo, MD, Erin Ahn, MS, Ju Li, PhD, Mathias J. Rummel, MD PhD, Jeff P Sharman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-134363
Published: 2020
Journal Articles

Final Analysis of the Ro-CHOP Phase III Study (Conducted by LYSA): Romidepsin Plus CHOP in Patients with Peripheral T-Cell Lymphoma

Emmanuel Bachy, MD PhD, Vincent Camus, Catherine Thieblemont, MD PhD, Rene-Olivier Casasnovas, MD, Loic Ysebaert, MD PhD, Gandhi Laurent Damaj, MD PhD, Stephanie Guidez, Gian-Matteo Pica, MD, Won Seog Kim, MD PhD, Soon Thye Lim, MBBS, MRCP, FAMS, Marc André, MD, Alejandro Martin Garcia-Sancho, MD PhD, Maria Jesus Penarrubia Ponce, MD, Philipp B. Staber, MD PhD, Judith Trotman, FRACP, Andreas Hüttmann, MD, Vittorio Stefoni, MD PhD, Alessandro Re, MD, Philippe Gaulard, MD PhD, Marie-Helene Delfau-Larue, MD PhD, Laurence De Leval, MD, Michel Meignan, MD, Ju Li, PhD, Franck Morschhauser, MD PhD, Richard Delarue, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-134440
Published: 2020
Journal Articles

Subgroup Analyses of Elderly Patients Aged ≥ 70 Years in MAGNIFY: A Phase IIIb Interim Analysis of Induction R 2 Followed By Maintenance in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Frederick Lansigan, MD, David Jacob Andorsky, MD, Morton Coleman, MD FACP, Abdulraheem Yacoub, MD, Jason M. Melear, MD, Suzanne R. Fanning, DO, Kathryn S. Kolibaba, MD, Christopher M. Reynolds, MD, Grzegorz S. Nowakowski, MD, Mecide Gharibo, MD, Erin Ahn, MS, Ju Li, PhD, Mathias J. Rummel, MD PhD, Jeff P Sharman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-134193
Published: 2020
Journal Articles

Aberrant Expression of MicroRNAs in CD4 + Cells May Contribute to the Imbalance of Th17/Treg Cells in Primary Immune Thrombocytopenia

Mingqiang Hua, Qi Feng, Ju Li, Yu Hou, Shuwen Wang, Anli Liu, Jun Peng, MDPhD, Ming Hou, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1140.
https://doi.org/10.1182/blood-2018-99-115569
Published: 2018
Journal Articles

The Reference Levels of Glucose-6-Phosphate Dehydrogenase Enzyme Activity for Infants in Taiwan

Meng-Ju Li, MD, M. Sci, Wen-Chien Yang, MD, Shin Tai, Chu-Ling Hsu, Pei-Lan Shao, MD, PhD, Ching-Tien Peng, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4741.
https://doi.org/10.1182/blood.V130.Suppl_1.4741.4741
Published: 2017
Journal Articles

Outcomes of Childhood Acute Lymphoblastic Leukemia with CNS-2, CNS-3 and Traumatic Lumbar Puncture with Blasts in Two Eras of Taiwan Pediatric Oncology Group (TPOG)-ALL-2002 Study with or without Cranial Radiation

Hsi-Che Liu, MD, Meng-Ju Li, MD, Hsiu-Ju Yen, MD, Dong-Tsamn Lin, MD, Tang-Her Jaing, MD, Ting-Chi Yeh, MD, Jen-Yin Hou, MD, Der-Cherng Liang, MD
Journal: Blood
Blood (2016) 128 (22): 1600.
https://doi.org/10.1182/blood.V128.22.1600.1600
Published: 2016
Journal Articles

Inflammation-Related Gene Polymorphisms Associated with Susceptibility to Primary Immune Thrombocytopenia

Ju Li, Sai Ma, Qi Feng, Ming Hou, Jun Peng
Journal: Blood
Blood (2016) 128 (22): 3737.
https://doi.org/10.1182/blood.V128.22.3737.3737
Published: 2016
Journal Articles

Phase II Multicenter Study of the Safety and Efficacy of Single-Agent Lenalidomide in Subjects with Relapsed/Refractory Mantle Cell Lymphoma: Long-Term Follow-up Analysis of the NHL-003 Study.

Pier Luigi Zinzani, MD, Julie M Vose, MD, MBA, Myron S. Czuczman, MD, Craig Reeder, MD, Corinne Haioun, MD, Jonathan Polikoff, MD, Herve Tilly, Dennis Pietronigro, Annette Ervin-Haynes, Ju Li, Thomas E. Witzig, MD
Journal: Blood
Blood (2012) 120 (21): 2738.
https://doi.org/10.1182/blood.V120.21.2738.2738
Published: 2012
Journal Articles

Prevalence & Prognosis Value of TET2 Gene Polymorphisms in Childhood Acute Myeloid Leukemia in Taiwan

Meng-Ju LI, MD, Yung-Li Yang, MD, Shiann-Tarng Jou, MD, Meng-Yao Lu, MD, Hsiu-Hao Chang, MD, Kai-Hsin Lin, MD, Dong-Tsamn Lin, MD, Ching-Tien Peng, MD, MPH
Journal: Blood
Blood (2011) 118 (21): 1551.
https://doi.org/10.1182/blood.V118.21.1551.1551
Published: 2011
Journal Articles

In Vitro Drug Sensitivity as a Predicitive Tool of Early Clinical Response in Childhood Acute Lymphoblastic Leukemia.

Faith C. Galderisi, DO, Linda C. Stork, MD, Ju Li, MD, Motomi Mori, PhD, Solange Mongoue-Tchokote, James Huang, MD
Journal: Blood
Blood (2007) 110 (11): 4232.
https://doi.org/10.1182/blood.V110.11.4232.4232
Published: 2007